Replies to post #12222 on Titan Pharmaceuticals Inc (TTNP)

[rikshot]

ProNeura patent runs out in June 2024----Plenty of time to sell out or be acquired. Hey !!!!! ----- BIG PHARMA----- One of you neeeeeeds to buy this mismanaged "Diamond in the Rough" just to show how lucrative it will be, in the right hands.----TOMORROW PLEASE !!!!! LOLOL

http://www.titanpharm.com/about/ip-portfolio

[Doctor Detroit]

The cool thing is that a ropinirole implant would provide the therapeutic agent and, through controlling titration, eliminate the need for a second drug to control the dyskinesia. But to your point..."What Me Worry" Bhonsle is not the dude that's going to get it done.